85 related articles for article (PubMed ID: 12688340)
1. Peripheral T-cell lymphomas: clinical features and prognostic factors of 92 cases defined by the revised European American lymphoma classification.
Arrowsmith ER; Macon WR; Kinney MC; Stein RS; Goodman SA; Morgan DS; Flexner JM; Cousar JB; Jagasia MH; McCurley TL; Greer JP
Leuk Lymphoma; 2003 Feb; 44(2):241-9. PubMed ID: 12688340
[TBL] [Abstract][Full Text] [Related]
2. Peripheral T cell lymphoma: Clinico-pathological characteristics & outcome from a tertiary care centre in south India.
Nemani S; Korula A; Agrawal B; Kavitha ML; Manipadam MT; Sigamani E; George B; Srivastava A; Viswabandya A; Mathews V
Indian J Med Res; 2018 May; 147(5):464-470. PubMed ID: 30082570
[TBL] [Abstract][Full Text] [Related]
3. Outcome of combined modality treatment in first-line for stage I(E) peripheral T-cell lymphoma; a nationwide population-based cohort study from the Netherlands.
Meeuwes FO; Brink M; Plattel W; Van der Poel MWM; Kersten MJ; Wondergem M; Böhmer L; Woei-A-Jin FJSH; Visser O; Oostvogels R; Jansen PM; Neelis KJ; Crijns APG; Daniëls LA; Snijders TJF; Vermaat JSP; Huls GA; Nijland M
Haematologica; 2024 Apr; 109(4):1163-1170. PubMed ID: 37794805
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylated STAT3 as a potential diagnostic and predictive biomarker in ALK
Xiang C; Wu W; Fan M; Wang Z; Feng X; Liu C; Liu J; Liu G; Xia L; Si H; Gu Y; Liu N; Luo D; Wang Y; Ma D; Hu S; Liu H
Front Immunol; 2023; 14():1132834. PubMed ID: 37388733
[TBL] [Abstract][Full Text] [Related]
5. Outcomes and prognostic factors in angioimmunoblastic T-cell lymphoma: final report from the international T-cell Project.
Advani RH; Skrypets T; Civallero M; Spinner MA; Manni M; Kim WS; Shustov AR; Horwitz SM; Hitz F; Cabrera ME; Dlouhy I; Vassallo J; Pileri SA; Inghirami G; Montoto S; Vitolo U; Radford J; Vose JM; Federico M
Blood; 2021 Jul; 138(3):213-220. PubMed ID: 34292324
[TBL] [Abstract][Full Text] [Related]
6. Pathobiology of nodal peripheral T-cell lymphomas: current understanding and future directions.
Bisig B; Savage KJ; De Leval L
Haematologica; 2023 Dec; 108(12):3227-3243. PubMed ID: 38037800
[TBL] [Abstract][Full Text] [Related]
7. Predictive model for treatment outcomes of peripheral T-cell lymphoma, not otherwise specified, in Taiwanese patients.
Chen NC; Chang H; Kuo MC; Lin TL; Shih LY; Chuang WY; Kao HW
J Formos Med Assoc; 2024 Feb; 123(2):188-197. PubMed ID: 37558588
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathologic characteristics of angioimmunoblastic T-cell lymphoma: analysis of the international peripheral T-cell lymphoma project.
Federico M; Rudiger T; Bellei M; Nathwani BN; Luminari S; Coiffier B; Harris NL; Jaffe ES; Pileri SA; Savage KJ; Weisenburger DD; Armitage JO; Mounier N; Vose JM
J Clin Oncol; 2013 Jan; 31(2):240-6. PubMed ID: 22869878
[TBL] [Abstract][Full Text] [Related]
9. Proliferative, pro-inflammatory, and angiogenesis regulator gene expression profile defines prognosis in different histopathological subtypes of nodal peripheral T-cell lymphoma.
de Pádua Covas Lage LA; Levy D; Xavier FD; Reis DC; de Oliveira Costa R; Gonçalves MC; Rocha V; Zerbini MCN; Pereira J
Oncotarget; 2019 Aug; 10(50):5136-5151. PubMed ID: 31497245
[TBL] [Abstract][Full Text] [Related]
10. Reproducing the molecular subclassification of peripheral T-cell lymphoma-NOS by immunohistochemistry.
Amador C; Greiner TC; Heavican TB; Smith LM; Galvis KT; Lone W; Bouska A; D'Amore F; Pedersen MB; Pileri S; Agostinelli C; Feldman AL; Rosenwald A; Ott G; Mottok A; Savage KJ; de Leval L; Gaulard P; Lim ST; Ong CK; Ondrejka SL; Song J; Campo E; Jaffe ES; Staudt LM; Rimsza LM; Vose J; Weisenburger DD; Chan WC; Iqbal J
Blood; 2019 Dec; 134(24):2159-2170. PubMed ID: 31562134
[TBL] [Abstract][Full Text] [Related]
11. Strategies for aggressive T-cell lymphoma: divide and conquer.
Pinter-Brown LC
Hematology Am Soc Hematol Educ Program; 2020 Dec; 2020(1):154-159. PubMed ID: 33275729
[TBL] [Abstract][Full Text] [Related]
12. 25-Hydroxy vitamin D deficiency is an inferior predictor of peripheral T-cell lymphomas.
Shen HR; Tang J; Li WY; Liang JH; Li Y; Wu JZ; Wang L; Li JY; Gao R; Yin H; Xu W
Ann Hematol; 2024 Feb; 103(2):565-574. PubMed ID: 37951853
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the prognostic impact of IPI and PIT in peripheral T-cell lymphoma in real-world practice with a large elderly population.
Nakamura N; Kanemura N; Matsumoto T; Nakamura H; Ikoma Y; Shibata Y; Kitagawa J; Kasahara S; Yamada T; Sawada M; Kaneda Y; Fukuno K; Takada E; Goto H; Lee S; Fujita K; Morishita T; Hara T; Tsurumi H; Shimizu M
Sci Rep; 2023 Nov; 13(1):19060. PubMed ID: 37925551
[TBL] [Abstract][Full Text] [Related]
14. The prognostic significance of POD24 in peripheral T-cell lymphoma.
Chen H; Ma R; Zhang Q; Lu F; Ma Y; Zhou J; Cao J; Qi K; Yan Z; Sang W; Zhu F; Sun H; Li D; Li Z; Cheng H; Xu K; Chen W
Hematology; 2024 Dec; 29(1):2304483. PubMed ID: 38251872
[TBL] [Abstract][Full Text] [Related]
15. Update on T-Cell Lymphoma Epidemiology.
Chen JJ; Tokumori FC; Del Guzzo C; Kim J; Ruan J
Curr Hematol Malig Rep; 2024 Mar; ():. PubMed ID: 38451372
[TBL] [Abstract][Full Text] [Related]
16. The SALENTO prognostic model for limited-stage peripheral T-cell lymphoma from the International T-Cell Project Network.
Hapgood G; Civallero M; Stepanishyna Y; Vose J; Cabrera ME; Advani RH; Pileri SA; Manni M; Horwitz SM; Foss FM; Hitz F; Radford J; Dlouhy I; Chiattone C; Kim WS; Skrypets T; Nagler A; Trotman J; Luminari S; Federico M
Blood Adv; 2023 Sep; 7(17):5047-5054. PubMed ID: 37163360
[TBL] [Abstract][Full Text] [Related]
17. Gene Expression Signatures for the Accurate Diagnosis of Peripheral T-Cell Lymphoma Entities in the Routine Clinical Practice.
Amador C; Bouska A; Wright G; Weisenburger DD; Feldman AL; Greiner TC; Lone W; Heavican T; Smith L; Pileri S; Tabanelli V; Ott G; Rosenwald A; Savage KJ; Slack G; Kim WS; Hyeh Y; Li Y; Dong G; Song J; Ondrejka S; Cook JR; Barrionuevo C; Lim ST; Ong CK; Chapman J; Inghirami G; Raess PW; Bhagavathi S; Gould C; Blombery P; Jaffe E; Morris SW; Rimsza LM; Vose JM; Staudt L; Chan WC; Iqbal J
J Clin Oncol; 2022 Dec; 40(36):4261-4275. PubMed ID: 35839444
[TBL] [Abstract][Full Text] [Related]
18. New strategies in peripheral T-cell lymphoma: understanding tumor biology and developing novel therapies.
Dunleavy K; Piekarz RL; Zain J; Janik JE; Wilson WH; O'Connor OA; Bates SE
Clin Cancer Res; 2010 Dec; 16(23):5608-17. PubMed ID: 21138864
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of BCL11b and CDKN2A in CD30-positive peripheral T cell lymphoma: Retrospective study.
Wang Y; Zhang F; Gao N; Bu P; Cui W; Xi Y
Medicine (Baltimore); 2023 Nov; 102(46):e35531. PubMed ID: 37986346
[TBL] [Abstract][Full Text] [Related]
20. A Systematic Review and Meta-Analysis of Front-line Anthracycline-Based Chemotherapy Regimens for Peripheral T-Cell Lymphoma.
Abouyabis AN; Shenoy PJ; Sinha R; Flowers CR; Lechowicz MJ
ISRN Hematol; 2011; 2011():623924. PubMed ID: 22084700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
